Skip to main content
The EMBO Journal logoLink to The EMBO Journal
. 1999 Sep 15;18(18):5061–5072. doi: 10.1093/emboj/18.18.5061

The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

D Patel 1, S M Huang 1, L A Baglia 1, D J McCance 1
PMCID: PMC1171577  PMID: 10487758

Abstract

The co-activators CBP and p300 are important for normal cell differentiation and cell cycle progression and are the targets for viral proteins that dysregulate these cellular processes. We show here that the E6 protein from the oncogenic human papillomavirus type 16 (HPV-16) binds to three regions (C/H1, C/H3 and the C-terminus) of both CBP and p300. The interaction of E6 with CBP/p300 was direct and independent of proteins known to bind the co-activators, such as p53. The E6 protein from low-risk HPV type 6 did not interact with C/H3 or the C-terminus but associated with the C/H1 domain at 50% of the level of HPV-16. HPV-16 E6 inhibited the intrinsic transcriptional activity of CBP/p300 and decreased the ability of p300 to activate p53- and NF-kappaB-responsive promoter elements. Interestingly, some mutations in HPV-16 E6 abrogated C/H3-E6 interactions, but did not alter the ability of E6 to associate with the C/H1 domain, suggesting that these modified proteins could be used to delineate the functional significance of the C/H1 and C/H3 domains of CBP/p300.

Full Text

The Full Text of this article is available as a PDF (446.8 KB).


Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES